Back 
Content with tag neulasta .
First long-acting biosimilar to help reduce infection risk during cancer treatment receives FDA approval
First long-acting biosimilar to help reduce infection risk during cancer treatment receives FDA approval The U.S. Food and Drug Administration (FDA) recently approved...